• Clinical queries - diagnoses, differentials, management protocols
• Pharmacology - pediatric dosing, drug mechanisms, interactions
• Case discussions - working through complex presentations
• Exam prep - DNB theory topics, important concepts
• Latest evidence - recent studies, updated guidelines (IAP, AAP, WHO)
• Pathophysiology - mechanisms behind pediatric conditions

Clinical Analysis: 4-year-old with 8-day fever + targetoid rash + bilateral conjunctivitis + cervical LAP

Your Child's Key Features (mapped clinically)

Differential Diagnosis - Working Through the Contenders

1. Erythema Multiforme Major (EM Major) - TOP of my list

"Erythema multiforme major is frequently accompanied by a febrile prodrome and sometimes arthralgias. Mucous membrane disease is prominent and often severely involves the oral mucosa and lips... The classic 'target' or 'iris' lesion with three zones: central dusky purpura; an elevated, edematous, pale ring; and surrounding macular erythema."

• Classic targetoid/iris lesions - this is the hallmark of EM, not SJS
• Started focally (popliteal region) - EM typically begins acrally/on extremities
• Non-itchy - EM lesions are typically non-pruritic
• Bilateral conjunctivitis - mucous membrane involvement typical of EM Major
• White patches in mouth - oral mucosal involvement
• 8-day fever - febrile prodrome is expected
• 4 years old - EM Major in children is most often caused by Mycoplasma pneumoniae

2. Kawasaki Disease (KD) - MUST NOT MISS

1. Bilateral non-exudative conjunctivitis ✅ (your child has this)
2. Mucous membrane changes (strawberry tongue, cracked lips, oral erythema) - white patches? possibly ✅
3. Rash (variable, non-vesicular) - targetoid? possibly ✅
4. Cervical LAP (≥1 node >1.5cm, usually unilateral) - your child has bilateral ⚠️
5. Extremity changes (erythema/edema hands-feet, later desquamation)

"The following findings should prompt a search for an alternative diagnosis: bullous, vesicular, or petechial rash; oral ulcers; pharyngeal or conjunctival exudates; generalized lymphadenopathy or splenomegaly."

3. Stevens-Johnson Syndrome (SJS) - Less likely but must exclude

"SJS is distinguished morphologically by the presence of purpura or bullae in macular lesions of the trunk."

• SJS is almost always drug-induced in children (sulfonamides, antiepileptics, NSAIDs, penicillins) - was any drug given before the rash?
• SJS rash begins on the trunk, not the popliteal region
• SJS causes mucosal erosions/ulceration, not just white patches
• SJS has skin detachment (Nikolsky sign positive) - is Nikolsky positive here?
• Cervical LAP is not a typical SJS feature

4. Adenovirus - Partial fit

• True targetoid/iris lesions
• Prolonged 8-day fever (adenovirus usually self-limits in 5-7 days)
• The constellation you're describing fits a more systemic immunologic process

"An exception is the patient with fever, exudative conjunctivitis, and exudative pharyngitis, in whom adenovirus is detected. In such cases, Kawasaki disease is considered extremely unlikely."

My Diagnostic Hierarchy for This Child

Priority 1: Rule out Kawasaki Disease (most dangerous if missed)
Priority 2: EM Major from Mycoplasma (most likely diagnosis)
Priority 3: SJS (if drug history found)
Priority 4: Adenoviral illness (less likely given non-exudative conjunctivitis)

Workup I Would Suggest

The Critical Decision Point

One More Thought - MIS-C

• Andrews' Diseases of the Skin, pp. 165-167
• Red Book 2021 (AAP), pp. 737-738
• Tintinalli's Emergency Medicine, p. 984

🚨 This child is in cardiac distress - Act NOW

What the New Findings Tell You

"Carditis can involve the pericardium, myocardium, or endocardium... pericardial effusion of at least 1mm (<5% of cases), myocarditis manifesting as congestive heart failure (<5%)." "Persistent resting tachycardia and a hyperdynamic precordium are common. Carditis generally resolves when fever resolves."

Working Diagnosis: Kawasaki Disease with Cardiac Involvement ± MIS-C

1. ✅ Fever ≥5 days (8 days)
2. ✅ Bilateral non-exudative conjunctivitis
3. ✅ Mucous membrane changes (white patches, congested throat)
4. ✅ Rash (targetoid/circular)
5. ✅ Cervical LAP (bilateral)
6. ✅ Echo: pericardial effusion + LV dysfunction (echo positive for KD purposes per AHA algorithm)
7. ✅ CRP >>3 mg/dL

"Decreased left ventricular function, mitral regurgitation, pericardial effusion, or z scores in LAD or RCA of 2 to 2.5."

KD vs MIS-C - Important Distinction Right Now

"IVIG as monotherapy was associated with higher risk of progressing to cardiac dysfunction... IVIG plus infliximab led to lower requirements for additional therapy and decreased ICU stay" (for MIS-C)

• Troponin + BNP/NT-proBNP (if very high = MIS-C)
• Platelet count (thrombocytosis = KD; thrombocytopenia = MIS-C)
• COVID-19 serology / antigen (positive = MIS-C more likely)
• Absolute lymphocyte count (lymphopenia = MIS-C)

Treatment - What to Do RIGHT NOW

Immediate (today, do not wait):

"IGIV plus aspirin is the treatment of choice and should be initiated as soon as the diagnosis is established or strongly suspected... whether or not coronary artery abnormalities are detected." "A single dose of IGIV 2g/kg... results in rapid resolution of fever and reduces risk of coronary artery aneurysms from 17% to 4%." - Red Book 2021

• High-dose (anti-inflammatory): 80-100 mg/kg/day in 4 divided doses (Western guideline) OR 30-50 mg/kg/day (Indian/Japanese guideline - check your institutional protocol) - continue until afebrile for 48-72 hours
• Then switch to low-dose (antithrombotic): 3-5 mg/kg/day single dose until echo at 6-8 weeks is normal

• Continuous SpO2 + HR monitoring (already tachycardic likely)
• Serial echo (repeat at 48-72 hrs after IVIG, again at 2 weeks, 6-8 weeks)
• Check coronary Z-scores specifically on the echo report - ask your cardiologist to measure LAD and RCA Z-scores if not already done

• Occurs in ~15% of patients
• Risk factors include: fever >10 days (this child = 8 days, so borderline), high CRP, hyponatremia, elevated ALT, thrombocytopenia
• If IVIG resistant: second dose IVIG or IV methylprednisolone 30 mg/kg/dose OR infliximab

If MIS-C cannot be excluded:

• Add IV methylprednisolone (1-2 mg/kg/day) alongside IVIG - current MIS-C guidelines support corticosteroids + IVIG
• Avoid NSAIDs (aspirin) if troponin very high or if active shock

Monitoring Over Next 24-48 Hours

Also Send Today (if not already done)

• Troponin I + BNP/NT-proBNP
• Platelet count (part of CBC)
• Serum albumin (hypoalbuminemia is a KD severity marker)
• Serum sodium (hyponatremia = higher IVIG resistance risk)
• ALT/LFT
• COVID antigen/antibody serology
• Blood culture (before IVIG if possible - rule out bacterial sepsis)
• Ferritin (if very high >500, consider MAS/macrophage activation syndrome overlap)

Bottom Line

• Red Book 2021 (AAP Committee on Infectious Diseases), pp. 738-744
• Firestein & Kelley's Textbook of Rheumatology, p. 2596 (MIS-C criteria table)
• Tintinalli's Emergency Medicine, p. 984

Dengue: Complete Bedside Guide for a 4-Day NS1-Positive Child

Step 1: Understand Where Day 4 Sits in the Dengue Timeline

Day 1-3/4 ──────► Day 3-7 ──────────────► Day 7-10+
FEBRILE PHASE    CRITICAL PHASE          CONVALESCENT PHASE
High fever        Plasma leakage          Fever gone
Viremia (NS1+)   ↑↑ Hematocrit           Rash reappears
Myalgia, rash    Thrombocytopenia nadir  Bradycardia
Leukopenia       Shock risk              Reabsorption of fluids

"Warning signs of progression to severe dengue occur in the late febrile phase... a rapid decline in platelet count with an increase in hematocrit."

Step 2: Classify Your Patient RIGHT NOW (WHO 2009)

Group A - Dengue WITHOUT Warning Signs

• Nausea/vomiting
• Rash
• Aches and pains
• Leukopenia
• Positive tourniquet test

Group B - Dengue WITH Warning Signs ⚠️ (Admit mandatorily)

Group C - SEVERE Dengue 🚨 (PICU)

• Severe plasma leakage → shock (dengue shock syndrome) or respiratory distress from effusions
• Severe bleeding (clinician-evaluated)
• Severe organ involvement: AST/ALT ≥1000 IU/L, impaired consciousness, cardiac/other organ failure

Step 3: History to Take at Bedside

• Which day of fever is today? (Day 4 = you have ~24-48 hrs to the nadir)
• Previous dengue? (Secondary infection = higher DHF/DSS risk due to antibody-dependent enhancement)
• Any warning signs from the list above?
• Fluid intake/urine output - is the child drinking? When was last urine?
• Any bleeding - petechiae, gum bleed, dark stools, blood in urine?
• Any drugs given? - Ibuprofen/aspirin given outside? This is dangerous - increases bleeding risk
• Comorbidities - asthma, sickle cell, diabetes, obesity increase severe disease risk

Step 4: Examination Checklist

Step 5: Labs - What to Order and How to Interpret

Essential labs RIGHT NOW (day 4):

"Dengue virus NS1 antigen detectable from beginning of febrile phase until day 7-10... NS1 + anti-dengue IgM in single specimen identifies ≥90% of cases."

Serial monitoring schedule (the most important thing at day 4):

• CBC every 6-12 hours during critical phase (days 3-7)
• Plot the platelet trend - a rapid fall predicts upcoming shock more than the absolute number
• Rising HCT + falling platelets simultaneously = plasma leakage is happening

Step 6: Fluid Management (THE KEY SKILL)

• Underfluid → unrecognized shock → organ failure
• Overfluid → fluid overload during reabsorption phase → pulmonary edema

WHO Fluid Algorithm:

• Oral rehydration - encourage water, ORS, juice, coconut water
• ORS 5 mL/kg/hour
• Monitor urine output (target 0.5-1 mL/kg/hr)
• Return precautions given to parents

• IV fluid: isotonic crystalloid (NS or RL)
• Starting rate: 5-7 mL/kg/hr for 1-2 hours
• Then reassess perfusion:
  • Improving → reduce to 3-5 mL/kg/hr × 2-4 hrs → 2-3 mL/kg/hr
  • Not improving → 10 mL/kg/hr bolus → reassess

• Bolus 10-20 mL/kg isotonic crystalloid over 15-30 min
• Reassess after each bolus
• If no improvement after 2 crystalloid boluses → consider colloid (20% albumin or dextran)
• Avoid over-bolusing - once plasma leakage stops (reabsorption), excess fluid cannot be excreted easily

Red flags for fluid overload (especially in reabsorption phase, day 7+):

• New respiratory distress after defervescence
• Increasing pulmonary edema on X-ray
• Falling HCT with improvement in symptoms = reabsorption happening - reduce fluids

Step 7: What NOT to Give in Dengue

Step 8: Platelet Transfusion - When to Give

Platelet transfusion does NOT prevent dengue hemorrhage and may worsen fluid overload.

Step 9: Warning Signs to Counsel Parents About (Discharge checklist if sending home)

1. No urine for 6 hours
2. Severe abdominal pain
3. Vomiting everything, cannot drink
4. Bleeding from any site - gums, nose, in vomit, black stools
5. Child becomes very sleepy, cannot be woken, confused
6. Cold hands and feet, fast breathing
7. Fever goes away but child looks sicker (= entering critical phase)

Step 10: Atypical/Expanded Dengue Syndrome - Don't Miss

• Dengue myocarditis - arrhythmia, LV dysfunction (check troponin/ECG if tachycardia disproportionate)
• Dengue encephalitis/meningoencephalitis - seizures, altered sensorium
• Dengue hepatitis - jaundice + very high transaminases
• Dengue-associated HLH - persistent fever, massive splenomegaly, pancytopenia, very high ferritin
• Dengue ADEM (rare) - post-dengue neurological deterioration

Summary Decision Tree for Your Day-4 Patient Right Now

NS1 positive, Day 4 of fever
           ↓
Does child have any Warning Signs?
    YES                     NO
     ↓                       ↓
ADMIT                   Is child tolerating
IV fluids               oral fluids well?
Serial CBC                YES → Send home
Watch HCT                 with strict return
+ platelets               precautions + CBC
6-hourly                  next day

• Red Book 2021 (AAP), pp. 520-524
• Harrison's Principles of Internal Medicine 22E, p. 3901